Covered recipient · General Payments record
ROSS E NUNES
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2019–2025
$1,832.04
- Reported across 121 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $208.18 | 9 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Vanda Pharmaceuticals Inc. | $77.95 | 4 |
| Janssen Pharmaceuticals, Inc | $43.88 | 1 |
| Neuronetics, Inc. | $42.58 | 2 |
| Teva Pharmaceuticals USA, Inc. | $22.16 | 1 |
| E.R. Squibb & Sons, L.L.C. | $21.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $21.61 | 01/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184943943 | CMS |
| Janssen Pharmaceuticals, Inc | $43.88 | 07/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174478425 | CMS |
| Neuronetics, Inc. | $15.60 | 06/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1163236647 | CMS |
| Neuronetics, Inc. | $26.98 | 06/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1163236649 | CMS |
| Teva Pharmaceuticals USA, Inc. | $22.16 | 05/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247371715 | CMS |
| Vanda Pharmaceuticals Inc. | $33.78 | 11/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232990595 | CMS |
| Vanda Pharmaceuticals Inc. | $15.38 | 11/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232990597 | CMS |
| Vanda Pharmaceuticals Inc. | $14.31 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232990599 | CMS |
| Vanda Pharmaceuticals Inc. | $14.48 | 12/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232990601 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.